RE:Another raise hahahaDumbeldorfwhite wrote: Who got the email? Let me guess "funds will be used for toxicology studies, completion of the bladder trial, and general expenses"
This study is so far behind it's laughable. Let me guess deathxray is still blaming the pandemic.
toxicology studies have been ongoing for quite literally years
"RuvidarTM is far more potent than any of the others we have worked with, in fact RuvidarTM is effective at concentrations approximately 100-fold lower than those we have previously tested. I believe RuvidarTM has the potential to be effective as a broad-spectrum viral vaccine able to mitigate the biothreat of various emerging infectious disease pathogens. In our research, we found that nanomolar and micromolar concentrations of RuvidarTMwere all that was required in order to inactivate 90 to 99.9% of all seven viruses that we tested, including H1N1 influenza virus, coronavirus, Zika virus, poxvirus and herpes virus. In fact, RuvidarTM at 3 mM completely killed the herpes virus."